Recent News

• 08.13.2025 - Mersana Q2 2025 Conference Call
• 08.13.2025 - Mersana Q2 2025 Conference Call
• 08.13.2025 - Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results
• 08.13.2025 - Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results
• 08.13.2025 - Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results
• 08.06.2025 - Mersana Therapeutics to Host Second Quarter 2025 Conference Call on August 13, 2025
• 08.06.2025 - Mersana Therapeutics to Host Second Quarter 2025 Conference Call on August 13, 2025
• 08.06.2025 - Mersana Therapeutics to Host Second Quarter 2025 Conference Call on August 13, 2025
• 07.24.2025 - Mersana Therapeutics Announces 1-for-25 Reverse Stock Split
• 07.24.2025 - Mersana Therapeutics Announces 1-for-25 Reverse Stock Split

Recent Filings

• 08.13.2025 - 8-K Current report
• 08.13.2025 - EX-99.1 EX-99.1
• 08.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.24.2025 - 8-K Current report
• 07.17.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.03.2025 - 8-K Current report
• 06.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.13.2025 - 4 Statement of changes in beneficial ownership of securities